2025-03-31 19:44:23
Latest Post
NHPC commissions 3 units of Parbati-II HE project
ixigo announces APRIL FULL REFUND SALE for 1st April - 100 Lucky Travellers To Win 100% Refund on Flight Bookings
Engineers India Ltd receives orders worth Rs. 245 crores
Blue Star appoints Mohit Sud as Group President, Unitary Cooling Products 
Jyoti Ltd receives Rs. 108.17 crores IT demand notice for AY 2020-21
Stock Report
Gujarat Themis Biosyn Ltd reports net profit of Rs. 13.79 crore in Q2 FY22
Posted On : 2021-11-11 22:39:34( TIMEZONE : IST )
GUJARAT THEMIS BIOSYN LTD. has reported Standalone financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 35.7613 crores during the period ended September 30, 2021 as compared to Rs. 33.5735 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 13.7920 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 12.9227 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 9.49 for the period ended September 30, 2021 as compared to Rs. 8.89 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 35.7613 crs | ₹33.5735 crs |  6.52% |
| Net Profit | ₹13.7920 crs | ₹12.9227 crs | 6.73% |
| EPS | ₹9.49 | ₹8.89 | 6.75% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 35.7613 crores during the period ended September 30, 2021 as compared to Rs.28.1491 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.13.7920 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.11.3463 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.9.49 for the period ended September 30, 2021 as compared to Rs.7.81 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 35.7613 crs | ₹28.1491 crs | 27.04% |
| Net Profit | ₹13.7920 crs | ₹11.3463 crs | 21.56% |
| EPS | ₹9.49 | ₹7.81 | 21.51% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.69.3348 crores during the 6 Months period ended September 30, 2021 as compared to Rs.44.6715 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.26.7147 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.16.9188 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.18.39 for the 6 Months period ended September 30, 2021 as compared to Rs.11.65 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹69.3348 crs | ₹44.6715 crs | 55.21% |
| Net Profit | ₹26.7147 crs | ₹16.9188 crs | 57.90% |
| EPS | ₹18.39 | ₹11.65 | 57.85% |
Shares of GUJARAT THEMIS BIOSYN LTD. was last trading in BSE at Rs. 572.90 as compared to the previous close of Rs. 571.20. The total number of shares traded during the day was 10214 in over 282 trades.
The stock hit an intraday high of Rs. 584.55 and intraday low of 560.25. The net turnover during the day was Rs. 5883882.00.
